Valuation: Takeda Pharmaceutical Company Limited

Market Cap 8,467B 52.33B 45.87B 42.3B 39.07B 74.07B 4,991B 75.31B 502B 198B 2,459B 197B 192B P/E 2027 *
43.6x
P/E 2028 * 27.9x
Enterprise Value 12,352B 76.35B 66.92B 61.71B 57.01B 108B 7,282B 110B 732B 289B 3,588B 287B 281B EV / Sales 2027 *
2.67x
EV / Sales 2028 * 2.6x
Free-Float
99.26%
Yield 2027 *
3.81%
Yield 2028 * 3.89%
1 day-0.72%
1 week+1.61%
Current month+3.96%
1 month+7.72%
3 months-7.94%
6 months+5.49%
Current year+10.84%
1 week 5,300
Extreme 5300
5,527
1 month 4,897
Extreme 4897
5,527
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer - 24/06/2026
Director of Finance/CFO 48 01/04/2024
Chief Tech/Sci/R&D Officer 47 01/02/2022
Director TitleAgeSince
Director/Board Member 60 01/06/2015
Director/Board Member 73 01/01/2019
Director/Board Member 48 01/06/2024
Date Insider Type Main position Quantity % Market Cap.
07-01Free

Executive/Senior Manager

49,558 0.0031%
07-01Free

Chief Technology Officer

125,390 0.0079%
07-01Free

Executive/Senior Manager

45,140 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
-0.72%+1.61%+20.97%+21.52% 52.53B
-2.33%-0.96%+50.33%+162.29% 1,085B
-0.82%-0.91%+62.97%+61.11% 624B
-0.73%-2.62%+27.22%+84.46% 442B
+0.33%-1.43%+29.46%+26.92% 332B
-0.02%-2.92%+27.40%+46.37% 282B
-3.89%-11.72%+23.86%+26.94% 277B
+0.66%-2.94%-27.27%-39.99% 217B
-0.06%-0.83%+20.98%+61.70% 196B
-3.72%+0.17%+13.35%+71.53% 167B
Average -1.13%-1.44%+24.93%+52.28% 367.45B
Weighted average by Cap. -1.32%-1.01%+35.81%+80.98%

Financials

2027 *2028 *
Net sales 4,630B 28.62B 25.09B 23.13B 21.37B 40.51B 2,730B 41.19B 274B 108B 1,345B 108B 105B 4,701B 29.06B 25.47B 23.48B 21.69B 41.13B 2,771B 41.81B 279B 110B 1,365B 109B 107B
Net income 184B 1.14B 996M 919M 849M 1.61B 108B 1.64B 10.9B 4.3B 53.41B 4.27B 4.18B 309B 1.91B 1.68B 1.55B 1.43B 2.71B 182B 2.75B 18.33B 7.24B 89.84B 7.18B 7.03B
Net Debt 3,886B 24.02B 21.05B 19.41B 17.93B 33.99B 2,291B 34.56B 230B 90.92B 1,129B 90.23B 88.27B 3,750B 23.18B 20.32B 18.74B 17.31B 32.81B 2,211B 33.36B 222B 87.76B 1,089B 87.09B 85.2B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
10/07/26 ¥5,359.00 -0.72% 3,123,700
09/07/26 ¥5,398.00 -0.97% 2,773,800
08/07/26 ¥5,451.00 +0.06% 3,668,900
07/07/26 ¥5,448.00 -1.25% 3,488,200
06/07/26 ¥5,517.00 +2.95% 3,686,800
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,359.00JPY
Average target price
6,106.87JPY
Spread / Average Target
+13.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock